Even H Rustad

1.4k total citations
23 papers, 308 citations indexed

About

Even H Rustad is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Even H Rustad has authored 23 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Even H Rustad's work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Even H Rustad is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Even H Rustad collaborates with scholars based in United States, Norway and Italy. Even H Rustad's co-authors include Ola Landgren, Francesco Maura, Malin Hultcrantz, Niccolò Bolli, Eileen M. Boyle, Gareth J. Morgan, Bachisio Ziccheddu, Kylee Maclachlan, Venkata D. Yellapantula and Benjamin Diamond and has published in prestigious journals such as Nature Communications, Blood and Nature Immunology.

In The Last Decade

Even H Rustad

21 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Even H Rustad United States 11 244 236 104 46 29 23 308
Colin A. Martz United States 4 104 0.4× 208 0.9× 83 0.8× 46 1.0× 19 0.7× 5 294
Sabine Juge Switzerland 7 155 0.6× 253 1.1× 49 0.5× 39 0.8× 8 0.3× 10 314
Ina van Zantwijk Netherlands 3 186 0.8× 327 1.4× 134 1.3× 16 0.3× 23 0.8× 8 389
Pauline Huyghe France 4 314 1.3× 262 1.1× 121 1.2× 24 0.5× 33 1.1× 9 389
Lars Fransecky Germany 8 99 0.4× 131 0.6× 104 1.0× 34 0.7× 21 0.7× 14 267
Marcela Braga Mansur Brazil 12 175 0.7× 134 0.6× 66 0.6× 36 0.8× 26 0.9× 28 341
Aneta Mikulášová United Kingdom 7 127 0.5× 164 0.7× 36 0.3× 29 0.6× 17 0.6× 24 205
Lukas John Germany 6 125 0.5× 113 0.5× 89 0.9× 26 0.6× 16 0.6× 20 210
Vaia Stavropoulou Switzerland 9 212 0.9× 269 1.1× 125 1.2× 57 1.2× 6 0.2× 18 417
Manuela Gambella Italy 8 193 0.8× 181 0.8× 116 1.1× 17 0.4× 17 0.6× 13 283

Countries citing papers authored by Even H Rustad

Since Specialization
Citations

This map shows the geographic impact of Even H Rustad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Even H Rustad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Even H Rustad more than expected).

Fields of papers citing papers by Even H Rustad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Even H Rustad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Even H Rustad. The network helps show where Even H Rustad may publish in the future.

Co-authorship network of co-authors of Even H Rustad

This figure shows the co-authorship network connecting the top 25 collaborators of Even H Rustad. A scholar is included among the top collaborators of Even H Rustad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Even H Rustad. Even H Rustad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinzelbecker, Julia, Natalie Chandler, Trung Tran, et al.. (2025). TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors. Nature Immunology. 26(10). 1726–1736.
2.
Tretbar, Sandy, Joel G. Rurik, Even H Rustad, et al.. (2024). Non-viral vectors for chimeric antigen receptor immunotherapy. Nature Reviews Methods Primers. 4(1). 5 indexed citations
3.
Meyer, Saskia, Ravi Chand Bollineni, Trung Tran, et al.. (2023). Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. Cell Reports. 42(1). 111995–111995. 20 indexed citations
4.
Misund, Kristine, Davine Hofste op Bruinink, Eivind Coward, et al.. (2022). Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. Leukemia. 36(7). 1887–1897. 34 indexed citations
5.
Maura, Francesco, Eileen M. Boyle, Even H Rustad, et al.. (2021). Chromothripsis as a pathogenic driver of multiple myeloma. Seminars in Cell and Developmental Biology. 123. 115–123. 25 indexed citations
6.
Maclachlan, Kylee, Even H Rustad, Andriy Derkach, et al.. (2021). Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma. Nature Communications. 12(1). 5172–5172. 26 indexed citations
7.
Rustad, Even H, Ferran Nadeu, Nicos Angelopoulos, et al.. (2021). mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies. Communications Biology. 4(1). 424–424. 17 indexed citations
8.
Ziccheddu, Bachisio, Giulia Biancon, Chiara De Philippis, et al.. (2020). Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma. Blood Advances. 4(5). 830–844. 49 indexed citations
9.
Diamond, Benjamin, Even H Rustad, Kylee Maclachlan, et al.. (2020). Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity. Blood Reviews. 46. 100732–100732. 17 indexed citations
10.
Hultcrantz, Malin, Venkata D. Yellapantula, & Even H Rustad. (2020). Genomic profiling of multiple myeloma: New insights and modern technologies. Best Practice & Research Clinical Haematology. 33(1). 101153–101153. 8 indexed citations
11.
Maura, Francesco, Even H Rustad, Eileen M. Boyle, & Gareth J. Morgan. (2020). Reconstructing the evolutionary history of multiple myeloma. Best Practice & Research Clinical Haematology. 33(1). 101145–101145. 17 indexed citations
12.
Maclachlan, Kylee, Binbin Zheng-Lin, Venkata Yellapantula, et al.. (2020). The Genomic Complexity of Multiple Myeloma Precursor Disease Can be Predicted Using Copy Number Signatures on Targeted Sequencing and SNP Array Data. Blood. 136(Supplement 1). 10–10. 2 indexed citations
13.
Eveillard, Marion, Even H Rustad, Mikhail Roshal, et al.. (2019). Comparison of MALDI-TOF Mass Spectrometry Analysis of Peripheral Blood and Bone Marrow Based Flow Cytometry for Tracking Measurable Residual Disease (MRD) in Patients with Multiple Myeloma. Blood. 134(Supplement_1). 3060–3060. 1 indexed citations
14.
Maura, Francesco, Niccolò Bolli, Even H Rustad, et al.. (2019). Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma. JAMA Oncology. 6(3). 425–425. 25 indexed citations
15.
Hultcrantz, Malin, Even H Rustad, Venkata Yellapantula, et al.. (2018). Capture Rate of the Adaptive Next Generation Sequencing VDJ Assay in Multiple Myeloma. Blood. 132(Supplement 1). 3184–3184. 3 indexed citations
16.
Rustad, Even H, Venkata Yellapantula, Neha Korde, et al.. (2018). Identifying Ultra-High Risk Smoldering Multiple Myeloma. Blood. 132(Supplement 1). 3192–3192. 1 indexed citations
17.
Landgren, Ola & Even H Rustad. (2018). Meeting report: Advances in minimal residual disease testing in multiple myeloma 2018. 2(1). e26–e26. 17 indexed citations
18.
Hultcrantz, Malin, Venkata D. Yellapantula, Even H Rustad, et al.. (2018). Mytype targeted next generation sequencing assay for detection of igh translocations and copy number alterations in multiple myeloma. 2. 213–214. 1 indexed citations
19.
Yellapantula, Venkata, Even H Rustad, Gunes Gundem, et al.. (2018). Whole Genome Sequencing of Extramedullary Myeloma Autopsy Tumors Reveals a Genomic Portrait at Culmination of Clonal Convergence. Blood. 132(Supplement 1). 3169–3169. 1 indexed citations
20.
Rustad, Even H, Hong Dai, Eivind Coward, et al.. (2015). Detection and Monitoring of BRAF and NRAS Mutant Clones in Myeloma Patients By Digital PCR of Circulating DNA. Blood. 126(23). 4196–4196. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin A. Martz Breakdown of academic impact, for papers by Sabine Juge Breakdown of academic impact, for papers by Ina van Zantwijk Breakdown of academic impact, for papers by Pauline Huyghe Breakdown of academic impact, for papers by Lars Fransecky Breakdown of academic impact, for papers by Marcela Braga Mansur Breakdown of academic impact, for papers by Aneta Mikulášová Breakdown of academic impact, for papers by Lukas John Breakdown of academic impact, for papers by Vaia Stavropoulou Breakdown of academic impact, for papers by Manuela Gambella
Rankless by CCL
2026